0 likes | 420 Views
SFDA-2007?????? ?????? ?????? ??????? . General Outline. I. Introduction and Background: The transitional state between the Saudi MOH and the Saudi FDA.Bioequivalence studies as essential part of the registration dossier.SFDA future expectations.II. Bioequivalence Workshop ObjectivesIII. Conclusions .
E N D